Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California Article Swipe
Andrew A. Herring
,
Mariah M. Kalmin
,
Melissa Speener
,
David Goodman‐Meza
,
Hannah Snyder
,
Arianna Campbell
,
Aimee Moulin
,
Steven Shoptaw
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1016/j.jsat.2020.108260
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1016/j.jsat.2020.108260
Related Topics
Concepts
Buprenorphine
Opioid use disorder
Medicine
Emergency department
Referral
Emergency medicine
Medical prescription
Family medicine
Opioid
Psychiatry
Internal medicine
Pharmacology
Receptor
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.jsat.2020.108260
- http://www.jsatjournal.com/article/S0740547220305171/pdf
- OA Status
- bronze
- Cited By
- 20
- References
- 13
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3113924551
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3113924551Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.jsat.2020.108260Digital Object Identifier
- Title
-
Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in CaliforniaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-12-27Full publication date if available
- Authors
-
Andrew A. Herring, Mariah M. Kalmin, Melissa Speener, David Goodman‐Meza, Hannah Snyder, Arianna Campbell, Aimee Moulin, Steven ShoptawList of authors in order
- Landing page
-
https://doi.org/10.1016/j.jsat.2020.108260Publisher landing page
- PDF URL
-
https://www.jsatjournal.com/article/S0740547220305171/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.jsatjournal.com/article/S0740547220305171/pdfDirect OA link when available
- Concepts
-
Buprenorphine, Opioid use disorder, Medicine, Emergency department, Referral, Emergency medicine, Medical prescription, Family medicine, Opioid, Psychiatry, Internal medicine, Pharmacology, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
20Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 3, 2023: 5, 2022: 4, 2021: 6Per-year citation counts (last 5 years)
- References (count)
-
13Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3113924551 |
|---|---|
| doi | https://doi.org/10.1016/j.jsat.2020.108260 |
| ids.doi | https://doi.org/10.1016/j.jsat.2020.108260 |
| ids.mag | 3113924551 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33612194 |
| ids.openalex | https://openalex.org/W3113924551 |
| fwci | 3.20515822 |
| mesh[0].qualifier_ui | Q000008 |
| mesh[0].descriptor_ui | D002047 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | administration & dosage |
| mesh[0].descriptor_name | Buprenorphine |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D002047 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Buprenorphine |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D002140 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | California |
| mesh[4].qualifier_ui | Q000706 |
| mesh[4].descriptor_ui | D004636 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | statistics & numerical data |
| mesh[4].descriptor_name | Emergency Service, Hospital |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | Q000008 |
| mesh[6].descriptor_ui | D009292 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | administration & dosage |
| mesh[6].descriptor_name | Narcotic Antagonists |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D009292 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Narcotic Antagonists |
| mesh[8].qualifier_ui | Q000188 |
| mesh[8].descriptor_ui | D009293 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | drug therapy |
| mesh[8].descriptor_name | Opioid-Related Disorders |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D017063 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Outcome Assessment, Health Care |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D010818 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Practice Patterns, Physicians' |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000086402 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | SARS-CoV-2 |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D002047 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Buprenorphine |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D002047 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Buprenorphine |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000086382 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | COVID-19 |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D002140 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | California |
| mesh[16].qualifier_ui | Q000706 |
| mesh[16].descriptor_ui | D004636 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | statistics & numerical data |
| mesh[16].descriptor_name | Emergency Service, Hospital |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | Q000008 |
| mesh[18].descriptor_ui | D009292 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | administration & dosage |
| mesh[18].descriptor_name | Narcotic Antagonists |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D009292 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Narcotic Antagonists |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D009293 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Opioid-Related Disorders |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D017063 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Outcome Assessment, Health Care |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D010818 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Practice Patterns, Physicians' |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000086402 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | SARS-CoV-2 |
| type | article |
| title | Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California |
| biblio.issue | |
| biblio.volume | 123 |
| biblio.last_page | 108260 |
| biblio.first_page | 108260 |
| topics[0].id | https://openalex.org/T10576 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2739 |
| topics[0].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[0].display_name | Opioid Use Disorder Treatment |
| topics[1].id | https://openalex.org/T11095 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9987999796867371 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2711 |
| topics[1].subfield.display_name | Emergency Medicine |
| topics[1].display_name | Emergency and Acute Care Studies |
| topics[2].id | https://openalex.org/T10645 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9940000176429749 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2711 |
| topics[2].subfield.display_name | Emergency Medicine |
| topics[2].display_name | Cardiac Arrest and Resuscitation |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778949969 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9575262069702148 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q407721 |
| concepts[0].display_name | Buprenorphine |
| concepts[1].id | https://openalex.org/C2779418921 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8740417957305908 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1639178 |
| concepts[1].display_name | Opioid use disorder |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.7909157276153564 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2780724011 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5853139162063599 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1295316 |
| concepts[3].display_name | Emergency department |
| concepts[4].id | https://openalex.org/C2776135927 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5845919847488403 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q5242559 |
| concepts[4].display_name | Referral |
| concepts[5].id | https://openalex.org/C194828623 |
| concepts[5].level | 1 |
| concepts[5].score | 0.48573166131973267 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2861470 |
| concepts[5].display_name | Emergency medicine |
| concepts[6].id | https://openalex.org/C2426938 |
| concepts[6].level | 2 |
| concepts[6].score | 0.45935630798339844 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[6].display_name | Medical prescription |
| concepts[7].id | https://openalex.org/C512399662 |
| concepts[7].level | 1 |
| concepts[7].score | 0.30670830607414246 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[7].display_name | Family medicine |
| concepts[8].id | https://openalex.org/C2781063702 |
| concepts[8].level | 3 |
| concepts[8].score | 0.28262948989868164 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q427523 |
| concepts[8].display_name | Opioid |
| concepts[9].id | https://openalex.org/C118552586 |
| concepts[9].level | 1 |
| concepts[9].score | 0.2701837718486786 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[9].display_name | Psychiatry |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.12835758924484253 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C98274493 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[11].display_name | Pharmacology |
| concepts[12].id | https://openalex.org/C170493617 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[12].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/buprenorphine |
| keywords[0].score | 0.9575262069702148 |
| keywords[0].display_name | Buprenorphine |
| keywords[1].id | https://openalex.org/keywords/opioid-use-disorder |
| keywords[1].score | 0.8740417957305908 |
| keywords[1].display_name | Opioid use disorder |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.7909157276153564 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/emergency-department |
| keywords[3].score | 0.5853139162063599 |
| keywords[3].display_name | Emergency department |
| keywords[4].id | https://openalex.org/keywords/referral |
| keywords[4].score | 0.5845919847488403 |
| keywords[4].display_name | Referral |
| keywords[5].id | https://openalex.org/keywords/emergency-medicine |
| keywords[5].score | 0.48573166131973267 |
| keywords[5].display_name | Emergency medicine |
| keywords[6].id | https://openalex.org/keywords/medical-prescription |
| keywords[6].score | 0.45935630798339844 |
| keywords[6].display_name | Medical prescription |
| keywords[7].id | https://openalex.org/keywords/family-medicine |
| keywords[7].score | 0.30670830607414246 |
| keywords[7].display_name | Family medicine |
| keywords[8].id | https://openalex.org/keywords/opioid |
| keywords[8].score | 0.28262948989868164 |
| keywords[8].display_name | Opioid |
| keywords[9].id | https://openalex.org/keywords/psychiatry |
| keywords[9].score | 0.2701837718486786 |
| keywords[9].display_name | Psychiatry |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.12835758924484253 |
| keywords[10].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1016/j.jsat.2020.108260 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S82881359 |
| locations[0].source.issn | 0740-5472, 1873-6483 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0740-5472 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Substance Abuse Treatment |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | http://www.jsatjournal.com/article/S0740547220305171/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Substance Abuse Treatment |
| locations[0].landing_page_url | https://doi.org/10.1016/j.jsat.2020.108260 |
| locations[1].id | pmid:33612194 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of substance abuse treatment |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33612194 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7832157 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Subst Abuse Treat |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7832157 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5112082597 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Andrew A. Herring |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210111905 |
| authorships[0].affiliations[0].raw_affiliation_string | California Bridge Program, Public Health Institute, United States of America |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I2800769186, https://openalex.org/I4210096489 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Emergency Medicine and Internal Medicine, Highland Hospital—Alameda Health System, Oakland, CA, United States of America |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I180670191 |
| authorships[0].affiliations[2].raw_affiliation_string | University of California, San Francisco, San Francisco, CA, United States of America |
| authorships[0].institutions[0].id | https://openalex.org/I2800769186 |
| authorships[0].institutions[0].ror | https://ror.org/04hcg0q34 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2800769186 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Alameda Health System |
| authorships[0].institutions[1].id | https://openalex.org/I4210096489 |
| authorships[0].institutions[1].ror | https://ror.org/00wtgx181 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I2800769186, https://openalex.org/I4210096489 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | Highland Hospital |
| authorships[0].institutions[2].id | https://openalex.org/I4210111905 |
| authorships[0].institutions[2].ror | https://ror.org/019621n74 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I4210111905 |
| authorships[0].institutions[2].country_code | US |
| authorships[0].institutions[2].display_name | Public Health Institute |
| authorships[0].institutions[3].id | https://openalex.org/I180670191 |
| authorships[0].institutions[3].ror | https://ror.org/043mz5j54 |
| authorships[0].institutions[3].type | education |
| authorships[0].institutions[3].lineage | https://openalex.org/I180670191 |
| authorships[0].institutions[3].country_code | US |
| authorships[0].institutions[3].display_name | University of California, San Francisco |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Andrew A. Herring |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | California Bridge Program, Public Health Institute, United States of America, Department of Emergency Medicine and Internal Medicine, Highland Hospital—Alameda Health System, Oakland, CA, United States of America, University of California, San Francisco, San Francisco, CA, United States of America |
| authorships[1].author.id | https://openalex.org/A5048202034 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7329-8931 |
| authorships[1].author.display_name | Mariah M. Kalmin |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[1].institutions[0].id | https://openalex.org/I161318765 |
| authorships[1].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of California, Los Angeles |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mariah Kalmin |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[2].author.id | https://openalex.org/A5069086634 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Melissa Speener |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[2].institutions[0].id | https://openalex.org/I161318765 |
| authorships[2].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of California, Los Angeles |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Melissa Speener |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[3].author.id | https://openalex.org/A5084925972 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9382-3564 |
| authorships[3].author.display_name | David Goodman‐Meza |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I161318765 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[3].institutions[0].id | https://openalex.org/I161318765 |
| authorships[3].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of California, Los Angeles |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | David Goodman-Meza |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[4].author.id | https://openalex.org/A5047537950 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8120-3824 |
| authorships[4].author.display_name | Hannah Snyder |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210111905 |
| authorships[4].affiliations[0].raw_affiliation_string | California Bridge Program, Public Health Institute, United States of America |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I180670191 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA, United States of America |
| authorships[4].institutions[0].id | https://openalex.org/I4210111905 |
| authorships[4].institutions[0].ror | https://ror.org/019621n74 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210111905 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Public Health Institute |
| authorships[4].institutions[1].id | https://openalex.org/I180670191 |
| authorships[4].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | University of California, San Francisco |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Hannah Snyder |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | California Bridge Program, Public Health Institute, United States of America, Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA, United States of America |
| authorships[5].author.id | https://openalex.org/A5038567324 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Arianna Campbell |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210111905 |
| authorships[5].affiliations[0].raw_affiliation_string | California Bridge Program, Public Health Institute, United States of America |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210105076 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Emergency Medicine, Marshall Medical Center, Placerville, CA, United States of America |
| authorships[5].institutions[0].id | https://openalex.org/I4210105076 |
| authorships[5].institutions[0].ror | https://ror.org/01k5bte77 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210105076 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Marshall Medical Center |
| authorships[5].institutions[1].id | https://openalex.org/I4210111905 |
| authorships[5].institutions[1].ror | https://ror.org/019621n74 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210111905 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | Public Health Institute |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Arianna Campbell |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | California Bridge Program, Public Health Institute, United States of America, Department of Emergency Medicine, Marshall Medical Center, Placerville, CA, United States of America |
| authorships[6].author.id | https://openalex.org/A5033077002 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Aimee Moulin |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210160527 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Emergency Medicine and Psychiatry, UC Davis Medical Center, Sacramento, CA, United States of America |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210111905 |
| authorships[6].affiliations[1].raw_affiliation_string | California Bridge Program, Public Health Institute, United States of America |
| authorships[6].institutions[0].id | https://openalex.org/I4210111905 |
| authorships[6].institutions[0].ror | https://ror.org/019621n74 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210111905 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Public Health Institute |
| authorships[6].institutions[1].id | https://openalex.org/I4210160527 |
| authorships[6].institutions[1].ror | https://ror.org/05t6gpm70 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210160527 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | University of California Davis Medical Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Aimee Moulin |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | California Bridge Program, Public Health Institute, United States of America, Department of Emergency Medicine and Psychiatry, UC Davis Medical Center, Sacramento, CA, United States of America |
| authorships[7].author.id | https://openalex.org/A5059600880 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-3583-0026 |
| authorships[7].author.display_name | Steven Shoptaw |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America |
| authorships[7].institutions[0].id | https://openalex.org/I161318765 |
| authorships[7].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | University of California, Los Angeles |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Steve Shoptaw |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.jsatjournal.com/article/S0740547220305171/pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10576 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2739 |
| primary_topic.subfield.display_name | Public Health, Environmental and Occupational Health |
| primary_topic.display_name | Opioid Use Disorder Treatment |
| related_works | https://openalex.org/W3183150022, https://openalex.org/W4211068096, https://openalex.org/W4283446732, https://openalex.org/W4385737324, https://openalex.org/W4401538303, https://openalex.org/W4392132029, https://openalex.org/W2898142040, https://openalex.org/W4317734534, https://openalex.org/W4281262336, https://openalex.org/W2133413278 |
| cited_by_count | 20 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 5 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 4 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 6 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1016/j.jsat.2020.108260 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S82881359 |
| best_oa_location.source.issn | 0740-5472, 1873-6483 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0740-5472 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Substance Abuse Treatment |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | http://www.jsatjournal.com/article/S0740547220305171/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Substance Abuse Treatment |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.jsat.2020.108260 |
| primary_location.id | doi:10.1016/j.jsat.2020.108260 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S82881359 |
| primary_location.source.issn | 0740-5472, 1873-6483 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0740-5472 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Substance Abuse Treatment |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | http://www.jsatjournal.com/article/S0740547220305171/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Substance Abuse Treatment |
| primary_location.landing_page_url | https://doi.org/10.1016/j.jsat.2020.108260 |
| publication_date | 2020-12-27 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W2282653375, https://openalex.org/W3033776099, https://openalex.org/W3081553985, https://openalex.org/W2906102371, https://openalex.org/W2158292788, https://openalex.org/W2906757530, https://openalex.org/W2792858351, https://openalex.org/W3030952681, https://openalex.org/W3080199520, https://openalex.org/W3043104358, https://openalex.org/W3014862161, https://openalex.org/W2946056695, https://openalex.org/W3034915101 |
| referenced_works_count | 13 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5112082597 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| corresponding_institution_ids | https://openalex.org/I180670191, https://openalex.org/I2800769186, https://openalex.org/I4210096489, https://openalex.org/I4210111905 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.9136694 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |